Search for: "Smithkline Beecham Corporation"
Results 41 - 60
of 83
Sort by Relevance
|
Sort by Date
15 Feb 2011, 4:06 am
SmithKline Beecham Corp. [read post]
3 Feb 2011, 2:11 pm
Smithkline Beecham Corp., 240 F.R.D. 179, 195 (E.D. [read post]
2 Feb 2011, 4:28 pm
SMITHKLINE BEECHAM CORPORATION, d.b.a. [read post]
19 Aug 2010, 10:27 am
Smithkline Beecham Corporation. [read post]
18 Aug 2010, 6:53 am
SmithKline Beecham Corp., 2010 WL 3119926 (E.D. [read post]
14 Jul 2010, 7:53 am
And it noted that federal courts have previously resolved conflicts between FDA labeling requirements and intellectual property law, including in SmithKline Beecham Consumer Healthcare, L.P. v. [read post]
12 Jul 2010, 11:34 pm
The New York Times reports that, as early as the fall of 1999, SmithKline Beecham, maker of a popular diabetes medicine called "Avandia", found out, through studies it conducted, that the drug posed significantly greater cardiac risks than other leading diabetes medicines. [read post]
6 Jul 2010, 2:51 am
., Serial No. 77136602 [Section 2(d) refusal to register the mark HD NOW for "Broadcasting services, namely, transmission of video advertising media and metadata via proprietary media management systems" in view of the identical mark registered for "radio broadcasting services of digital signals"].July 20 - 11 AM: SmithKline Beecham Corporation v. [read post]
10 May 2010, 5:33 am
Sadly, as the last part of that Kirchner cite reveals, the section 1447(d) issue in that case ultimately went the plaintiffs' way.The latest case of remand fever is Aaron v Smithkline Beecham Corp., 2010 WL 1752546 (S.D. [read post]
6 Apr 2010, 4:01 am
Smithkline Beecham Corporation, dba Glaxosmithkline, No. 09-10806 (11th Cir. [read post]
4 Mar 2010, 10:58 am
Smithkline Beecham Corp., 240 F.R.D. 179, 194-95 (E.D. [read post]
25 Feb 2010, 6:34 am
Smithkline Beecham Corporation, the Seventh Circuit rejected this argument in a case brought by a twenty-three-year-old woman who committed suicide two days after she started taking Paxil, a popular SSRI. [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
19 Oct 2009, 5:53 pm
It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline… [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
8 Oct 2009, 1:56 pm
PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
17 Sep 2009, 4:30 am
The corporate representative was "not responsible" for the conduct of the surgery. [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter China’s Essential Drug List… [read post]
14 Aug 2009, 1:04 am
SmithKline Beecham Corp., 2008 WL 2491965, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
SmithKline Beecham Corp., 2008 WL 2491965, at *7 (S.D. [read post]
